Calluna Pharma AS has announced the successful completion of Phase 1 clinical trials for its lead drug candidate, CAL101, a first-in-class monoclonal antibody (mAb) targeting fibrotic and ...

The two-year programme will use virtual reality technology to teach essential skills A £4.5m initiative has been launched to address the growing skills shortage in the UK’s medicines manufacturing ...

Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK The National Institute for Health and Care Excellence (NICE) has issued guidance recommending Santen’s ...

Oxford Drug Design has been awarded a share of a £3 million Collaborative Discovery Programme (CDP) by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate. This initiative, funded by the ...

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative ...

Study reveals potential new strategy for managing inflammatory bowel disease Celltrion has announced groundbreaking results from a two-year study on dose escalation of subcutaneous infliximab (CT-P13 ...

As the polls tighten and June’s general election starts to seem very close indeed, we’ve got a roundup of all the major parties’ manifestos and what they would mean for healthcare in the UK. But ...

Innovative Trials has appointed Ian Keith as Finance and Business Services Director Innovative Trials has appointed Ian Keith, who has been supporting the company as a Business Consultant since the ...

In this issue, we present Alantra’s annual ranking of the 50 fastest-growing, privately owned pharma companies. Of particular note, every single company on this list has delivered annualised revenue ...

The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma Vivan Therapeutics has signed a new five-year lease at White City Place, a biotech hub in London home to ...

As the NHS goes, so goes pharma – so when the government talks about ‘transforming’ the health service, the industry better listen. Our cover feature this month (p33) focuses on sustainability and ...

There are around 55,100 new prostate cancer cases in the UK every year HBC Immunology (HBCI) has announced that an oral formulation of its lead peptide “significantly augmented” the anti-tumour ...